Atlas.
Sign inStart free trial
ATRCNASDAQ · US

AtriCure, Inc.

Technology · Surgical & Medical Instruments & Apparatus

TechnologySurgical & Medical Instruments & Apparatus
CEO
Michael H. Carrel
Founded
—
IPO Date
—
HQ
Mason, OH, United States
Exchange
NASDAQ
Employees
n.a.

Share Price Performance

$29.73 ▼ 24.3%
Last (1 Jul 2026) · $30
Period High · $42.41
Period Low · $25.86
52W: $25.86 – $42.41

Key Metrics

Share Price
$29.73
+6.3% today
Market Cap
$1.5B
P / E
—
EV / Revenue
2.6x
Revenue Growth
+14.9%
year-on-year
Gross Margin
+75.0%
Enterprise Value
$1.4B
52W High
$42.41
52W Low
$25.86
Avg Volume
803K
daily

Sources: SEC filings · Market data as of Jul 6, 2026

Shareholders' Structure
12 known institutional holders·$324M total on record·2026-Q1
BlackRock, Inc.
8.1%·$115M
Goldman Sachs Group Inc
3.4%·$48M
State Street Corp
2.6%·$37M
Geode Capital Management, LLC
2.5%·$35M
Dimensional Fund Advisors LP
2.0%·$28M
Bank Of America Corp
1.5%·$22M
Northern Trust Corp
0.9%·$13M
Fmr LLC
0.7%·$10M
Renaissance Technologies LLC
0.6%·$9M
Jpmorgan Chase & Co
0.3%·$5M
Invesco Ltd.
0.2%·$2M
Price T Rowe Associates Inc
0.1%·$1,720
Free Float
77.1%

Sources: SEC filings

Notes: % shown as share of total shares outstanding · Free float = shares outstanding minus all known 13F institutional holdings

What Atlas covers for AtriCure, Inc.
OverviewAtriCure, Inc. share price history (10 years), key market statistics, and institutional shareholder structure from SEC 13F-HR filings.Business ModelHow AtriCure, Inc. generates revenue — product and service segments, geographic breakdown, key operating metrics, and 10-year business evolution sourced from SEC filings.FinancialsAtriCure, Inc.'s complete financial history — 10 years of annual revenue, gross margins, operating income, net income, EPS, and free cash flow from SEC filings, plus 12 quarters of quarterly results.Management QualityAtriCure, Inc. executive team profiles, insider buying and selling from SEC Form 4, earnings call transcripts, and a track record of guidance delivery vs actual results.Risk FactorsAtriCure, Inc.'s annual risk disclosures from SEC filings — full text, 5-year evolution showing how risks have shifted, and year-on-year delta highlighting new and removed risks.NewsAI-synthesised news digest for AtriCure, Inc., updated regularly with key developments, earnings updates, product announcements, and material company events.SentimentInvestor sentiment for AtriCure, Inc. aggregated from X.com, Reddit, and Hacker News — discussion themes, Bull and Bear signals, and community analysis.Valuation & PeersAtriCure, Inc. valuation multiples — P/E, EV/Revenue, EV/EBITDA — compared against a curated set of industry peers using live data from SEC filings. Custom peer selection available.DCF BuilderBuild a discounted cash flow model for AtriCure, Inc. with 10 years of pre-filled revenue, margins, and cash flow data from SEC filings. Adjust growth rates, WACC, and terminal assumptions.Atlas AnalysisAtlas AI research synthesis for AtriCure, Inc. — business model, financial health, management quality, risk profile, and institutional ownership, grounded exclusively in SEC filings.

Unlock the full analysis

9-tab institutional research sourced directly from SEC filings. No tips, no scores — the same process professional investors use.

7-day free trial · Plus & Pro · No charge during trial